Karyopharm Therapeutics
KPTI
KPTI
155 hedge funds and large institutions have $1.32B invested in Karyopharm Therapeutics in 2020 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 65 increasing their positions, 33 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
155
Holders Change
+19
Holders Change %
+13.97%
% of All Funds
3.19%
Holding in Top 10
4
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-55.56%
% of All Funds
0.08%
New
44
Increased
65
Reduced
33
Closed
23
Calls
$14.8M
Puts
$6.38M
Net Calls
+$8.46M
Net Calls Change
+$7.98M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$25.6M |
| 2 |
BlackRock
New York
|
+$20.1M |
| 3 |
Goldman Sachs
New York
|
+$19.7M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$18M |
| 5 |
D.E. Shaw & Co
New York
|
+$10.8M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
DWA
176
Dorsey Wright & Associates
Pasadena,
California
| – | -$18K | -61 | Closed |
|
|
EWA
177
Evolution Wealth Advisors
Aventura,
Florida
| – | -$14K | -49 | Closed |
|
178
AssetMark Inc
Concord,
California
| – | -$2K | -6 | Closed |
|